Outpatient management in patients with neutropenia after intensive chemotherapy—is it safe?
Juvenile cancer: improving care for adolescents and young adults within the frame of medical oncology
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives
Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia
Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years
Can patients with early-stage diffuse large B-cell lymphoma be treated without bone marrow biopsy?
Biological modifiers as cytoreductive therapy before stem cell transplant in previously untreated patients with multiple myeloma
Long-term survival after surgical intervention for bone disease in multiple myeloma
Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials
Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate
Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes
Evaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)–paclitaxel or docetaxel adjuvant chemotherapy in breast cancer
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)
Development of axillary surgery in breast cancer
Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications
Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival
Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity
Phase II study of troxacitabine in chemotherapy-naïve patients with advanced cancer of the pancreas
Comparison of docetaxel and docetaxel–irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial
Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy
Calreticulin expression in neuroblastoma—a novel independent prognostic factor
A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations
Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity?
Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity?
Obesity may decrease the amenorrhea associated with chemotherapy in premenopausal breast cancer patients
Obesity may decrease the amenorrhea associated with chemotherapy in premenopausal breast cancer patients
Intra-arterial hepatic chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Multiple Myeloma and Related Disorders
Cancer Chemoprevention Vol. 1. Promising Cancer Chemopreventive Agents